Additional Metadata
Persistent URL dx.doi.org/10.3899/jrheum.170334, hdl.handle.net/1765/100850
Journal Journal of Rheumatology
Citation
Kuijper, T.M, Buisman, L.R, Hazes, J.M.W, & Weel, A.E.A.M. (2017). Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice. Journal of Rheumatology, 44(7), 965–967. doi:10.3899/jrheum.170334